Kadmon Website

Contact Information:
Steve Sjoquist
Steven.Sjoquist@kadmon.com
763-233-9532

Virtual Exhibit Hall Home

Kadmon is a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs. Our team has a proven track record of successful drug development and commercialization. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

REZUROCK™ (belumosudil) tablets is now approved. Please go to https://rezurockhcp.com  to find out more information.

Additional Information

REZUROCK Prescribing Information
Kadmon ASSIST Brochure
Patient Brochure
HCP Brochure​​​​​​​